Learn more about ACRO’s advocacy efforts in the United States and Europe
Artificial Intelligence & Machine Learning
ACRO’s AI/ML Committee brings together member company subject matter experts engaged in the development and use of AI/ML tools in the design, conduct, oversight, and analysis of clinical trials.
Diversity & Inclusion in Clinical Trials
ACRO’s Diversity and Inclusion in Clinical Trials Committee was formed in 2020 as a part of ACRO’s ongoing efforts to work towards advancing diversity, equity, and inclusion in the clinical research ecosystem.
Risk-Based Quality Management
Risk-based monitoring is an adaptive approach that directs monitoring focus and activities to the evolving areas of greatest need which have the most potential to impact patient safety and data quality.
ACRO MEMBERS
US Advocacy
ACRO works with US legislators and regulators to ensure a positive regulatory environment that supports high-quality, safe and ethical clinical research.
European Advocacy
ACRO engages with regulators and policymakers in the EU and UK to ensure a positive regulatory environment that supports high-quality, safe and ethical clinical research.
Subscribe for Updates
The Association of Clinical Research Organizations (ACRO) represents the leading clinical research and technology companies around the world. In our newsletter, we bring you updates on our work and the impact that we are having in advancing the global clinical research industry.
The Latest
Good Clinical Podcast – Season 3, Episode 10
Episode 10: Trends in Risk-Based Monitoring and RBQM in Clinical Trials Join three subject-matter experts…
Good Clinical Podcast – Season 3, Episode 9
Episode 9: Granting Access – Lessons from ACRO’s Site Grant Program In 2024, ACRO announced…
Good Clinical Podcast – Season 3, Episode 8
Episode 8: AI on the Prize How AI is Modernizing Clinical Operations In this week’s…
Site Resource Grant Spotlight: K2 Medical Research
ACRO’s Site Resource Grants are designed to serve as seed funding to help clinical research…
Good Clinical Podcast – Season 3, Episode 7: The Impact of ICH E6(R3)
Episode 7: The Impact of ICH E6(R3) – Sponsor and CRO Perspectives In ACRO and…
FDA Changes and Implications: What You Need to Know
In late March, a wave of changes at HHS and the FDA marked the beginning…
Good Clinical Podcast – Season 3, Episode 6: Strategic Uses of AI in Clinical Development
Episode 6: Strategic Uses of AI in Today’s Clinical Development Malaikannan Sankarasubbu and Jonathan Shough join the Good Clinical…